^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
CART-38
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
University of Pennsylvania
Drug class:
CD38-targeted CAR-T immunotherapy
Related drugs:
Phase 1
University of Pennsylvania
Recruiting
Last update posted :
06/22/2023
Initiation :
05/30/2023
Primary completion :
05/01/2041
Completion :
05/01/2041
CD38 • CD34
|
CD38 expression
|
cyclophosphamide • fludarabine IV • CART-38
Share
